Skip to main content

Day: July 19, 2022

Impel Pharmaceuticals Announces First Patient Dosed in Phase 2a Study Evaluating INP105 to Treat Acute Agitation in Adolescents With Autism Spectrum Disorder (ASD)

CALM 201 Study to Explore the Safety and Efficacy of Single 5mg-Dose INP105 Compared to Placebo in Quickly Reducing Agitation in Participants with ASD SEATTLE, July 19, 2022 (GLOBE NEWSWIRE) — Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced the first subject has been dosed in a Phase 2a proof-of-concept study of INP105, nasal olanzapine, a widely used atypical, second-generation antipsychotic. INP105 is being developed as an acute treatment for agitation in persons with autism spectrum disorder (ASD) using Impel’s proprietary Precision Olfactory Delivery (POD®) technology which delivers drugs to the upper nasal space. Results are expected in Q1 2023. CALM 201 (NCT05163717), “INP105...

Continue reading

Integra LifeSciences Appoints Renee Lo as Director

Renee Lo Appointed to Integra Board of DirectorsPRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the appointment of Renee Lo to its board of directors as an independent director to fill an existing vacancy, effective July 18, 2022. “Renee is a highly accomplished global leader in driving digital transformation across industries,” said Stuart Essig, chairman of the Integra board of directors. “Her experience and insights will be a strong complement to the board, and I look forward to partnering with Renee to deliver shareholder value and support the company’s ongoing success.” Ms. Lo currently serves as a general manager for Microsoft, leading its data and artificial intelligence business in Asia. She is responsible...

Continue reading

Katapult Hires New Chief Revenue Officer to Lead Revenue Operations and Fuel Next Stage of Company’s Growth

PLANO, Texas, July 19, 2022 (GLOBE NEWSWIRE) — Katapult Holdings, Inc., (NASDAQ:KPLT) a leading lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power online shopping for non-prime customers, has hired Reid Bork as the company’s Chief Revenue Officer (“CRO”). He will take charge of enhancing and optimizing Katapult’s customer base and sales team to continue the expansion of the company’s merchant partnerships and overall growth. In this position, Bork will play a critical role in building and leading the Katapult sales organization, working cross-functionally to develop and drive the end–to–end sales strategy. As CRO, he will define revenue cycles, go-to-market methods and expand the company’s sales team, leveraging analytics and data to drive predictable growth. “Reid has an established...

Continue reading

Cognition Therapeutics Presenting New Analyses from Ongoing Clinical Trial of CT1812 in Mild-to-Moderate Alzheimer’s Disease

 – Analyses Demonstrate CT1812 Impact on Alzheimer’s Disease Processes – NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) will be in attendance at the 2022 Alzheimer’s Association International Conference (AAIC) being held in San Diego, CA from July 31 to August 4, 2022. Cognition’s vice president of research, Mary Hamby, Ph.D. will present new proteomic analyses of disease biomarkers demonstrating the impact of CT1812 on disease processes in participants from the SPARC clinical study in mild-to-moderate Alzheimer’s disease. CT1812 is an oral, small molecule that selectively binds to the sigma-2 (σ-2) receptor complex. Evidence implicates σ-2 receptors in the regulation of key cellular processes that are damaged in Alzheimer’s disease, dementia with Lewy bodies (DLB) and other neurodegenerative...

Continue reading

GBT Researching Practical Applications of its Motion Detection Wireless Technology

The company is conducting experimental simulations and testing for possible implementations of its Apollo patent’s technology as a computer vision system SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), is researching practical applications implementation of its intelligent, wireless, motion detection patented technology, which has been assigned an internal code name “Apollo”. The non-provisional patent was granted on April 12, 2022, and protects real time, RF based technology to produce an accurate computer vision system. Apollo includes AI algorithms to control and analyze radio wave transmissions and their reflections to construct accurate 3D/2D imaging in real time. The patented IP describes a technology that can produce a high-resolution live video of objects...

Continue reading

Bit Origin Ltd Provides Operation Updates and Future Miner Deployment Schedule

New York, July 19, 2022 (GLOBE NEWSWIRE) — Bit Origin Ltd (NASDAQ: BTOG) (“Bit Origin” or the “Company”), an emerging growth company engaged in the crypto mining business with diversified expansion strategies, today provided its operation updates and future miner deployment schedule. “We have reached significant milestones in the past two months after our new management team took office at the end of April 2022. We completed the installations of our first batch of miners, mined our first bitcoin, and started critical developments of our mining sites,” said Mr. Lucas Wang, Chairman and Chief Executive Officer of the Company. “With over eight years of experience in crypto mining operation, our management team witnessed several boom and bust cycles of bitcoin, and we remain confident about...

Continue reading

VPG to Present at the Jefferies 2022 Industrials Conference on August 10, 2022

MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement sensing technologies, announced that the company will present at the Jefferies 2022 Industrials Conference on August 10, 2022 at 9:30 a.m. ET. A live and on-demand webcast of VPG’s presentation will be available to the public and can be accessed from the following link: https://wsw.com/webcast/jeff250/vpg/1706922, or on VPG’s website: ir.vpgsensors.com/events. For more information, or for help in arranging a one-on-one meeting at the conference, please contact: info@vpgsensors.com. About VPG Vishay Precision Group, Inc. (VPG) is a leader in precision measurement sensing technologies. Our sensors, weighing solutions and measurement systems optimize and enhance our customers’ product performance across a broad...

Continue reading

VYNE Therapeutics to Present at the B&T Cell-Mediated Autoimmune Disease Drug Development Conference

BRIDGEWATER, N.J., July 19, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical company developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions, today announced that Iain Stuart, Ph.D., Chief Scientific Officer of VYNE, will be presenting at the B&T Cell-Mediated Autoimmune Disease Drug Development Conference (in-person) on July 27, 2022.B&T Cell-Mediated Autoimmune Disease Drug Development Conference (in-person) – Presentation Details   Presentation Date: July 27, 2022   Presenter: Iain Stuart, Ph.D., Chief Scientific Officer of VYNE   Presentation Track: Harnessing Autoantibody Signatures and Mapping Out the B&T Cell-Mediated Autoimmune Disease Landscape   Presentation...

Continue reading

IPG Photonics to Announce Second Quarter 2022 Financial Results on August 2

OXFORD, Mass., July 19, 2022 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) will release its second quarter 2022 financial results before the market opens on Tuesday, August 2, 2022. The company will hold a conference call to review these results at 10:00 a.m. ET on the same day. To access the call, please dial 877-407-6184 in the United States or 201-389-0877 internationally. A live webcast of the call will also be available and archived in the investor relations section of the company’s website at investor.ipgphotonics.com. About IPG Photonics Corporation IPG Photonics Corporation is the leader in high-power fiber lasers and amplifiers used primarily in materials processing and other diverse applications. The company’s mission is to make its fiber laser technology the tool of choice in mass production. IPG accomplishes...

Continue reading

HP Welcomes Office Workers Back with Stylish, Intelligent Printers

Inspiring productivity and streamlining print transformation for IT teams News Highlights: Workers miss their office printer more than happy hour or a free lunch Work flows fast with the new HP LaserJet Managed E800/E700 series Bringing value to customers with a secure, customizable and easy-to-manage portfolioPALO ALTO, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Re-imagining the office experience, companies are resetting plans to cater to new ways of working. Tasked with creating modern and inspiring workplace environments, CIOs and ITDMs require the right technologies to enable a fast moving, digitally enabled workforce to be productive. A recent Morning Consult survey1, commissioned by HP, polled 1,000 office workers in the US and Canada to find out what they appreciate (and had missed) most about the office. It turns out,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.